VILDAVIB D 100/10DAPAGLIFLOZIN 10mg. IP + VILDAGLIPTIN 100mg. IP

Vildavib D 100/10 tablets combine Dapagliflozin 10 mg and Vildagliptin 100 mg to improve blood sugar control in type 2 diabetes. Main uses: as an add-on to diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus; helps lower blood sugar through two different actions: glucose loss in urine and improved insulin release; used as a single fixed combination when a doctor decides that both these medicines are needed together.

Common side effects of Vildavib D 100/10 Tablet include female genital mycotic (fungal) infections; nasopharyngitis (common cold-like symptoms); urinary tract infections; headache; dizziness; nausea. Get medical help at once if you notice diabetic ketoacidosis (can occur even if blood sugar is not very high); volume depletion or dehydration, especially in the elderly or with diuretics; severe genitourinary infection, including Fournier's gangrene.

Each Vildavib D 100/10 tablet contains Dapagliflozin 10 mg + Vildagliptin 100 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Vildavib D 100/10 Tablet only as your doctor advises.

The MRP of Vildavib D 100/10 Tablet is ₹187.5 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹142.86 and the PTS is ₹128.57.

Each Vildavib D 100/10 tablet contains Dapagliflozin 10 mg + Vildagliptin 100 mg. It comes in a pack of 10x10 (Alu Alu).

Dapagliflozin acts on the kidney by blocking the SGLT2 transporter, so less glucose is taken back into the blood and extra glucose leaves the body in urine. Vildagliptin works in a different way: it blocks the DPP-4 enzyme and raises incretin hormone levels, which helps the pancreas release insulin when blood sugar goes up and reduces glucose output from the liver. Together, the two ingredients help bring blood sugar levels down.

Must not be used by patients with a history of a serious hypersensitivity reaction to dapagliflozin, vildagliptin or any excipient of the tablet. Must not be used to improve blood sugar control in type 1 diabetes mellitus. Not recommended to improve blood sugar control when eGFR is below 45 mL/min/1.73 m2; kidney function and volume status should be assessed before starting. Check with a doctor first if you have kidney disease or reduced kidney function, liver disease, low blood pressure, dehydration or low fluid volume. Check with a doctor first if you take insulin, sulfonylureas or diuretics (water tablets), if you are pregnant or breastfeeding, or before surgery, prolonged fasting or illness.

Vildavib D 100/10 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.